Abstract
We present an analysis of three patients from literature with a malignancy treated with high-dose chemotherapy and hematopoietic stem cell transplantation. It is evident that schizophrenia can be transferred during the cell graft from a schizophrenic donor, cured by the graft from a healthy donor, or cured by high-dose therapy and an autologous graft. We suggest that the use of allogeneic MSCs from healthy donors (including MSCs soluble and insoluble paracrine factors) in schizophrenia patients may be an exciting therapeutic option for further exploration.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
